Cargando…

Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients

BACKGROUND: Tuberculosis lymphadenitis (TBLN) diagnosis is often challenging in most resource poor settings. Often cytopathologic diagnosis of TBLN suspected patients is inconclusive impeding timely clinical management of TBLN suspected patients, further exposing suspected patients either for unnece...

Descripción completa

Detalles Bibliográficos
Autores principales: Atnafu, Abay, Desta, Kassu, Girma, Selfu, Hailu, Dawit, Assefa, Gebeyehu, Araya, Shambel, Bekele, Dinksira, Wassie, Liya, Bobosha, Kidist
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970391/
https://www.ncbi.nlm.nih.gov/pubmed/35358212
http://dx.doi.org/10.1371/journal.pone.0265499
_version_ 1784679450120552448
author Atnafu, Abay
Desta, Kassu
Girma, Selfu
Hailu, Dawit
Assefa, Gebeyehu
Araya, Shambel
Bekele, Dinksira
Wassie, Liya
Bobosha, Kidist
author_facet Atnafu, Abay
Desta, Kassu
Girma, Selfu
Hailu, Dawit
Assefa, Gebeyehu
Araya, Shambel
Bekele, Dinksira
Wassie, Liya
Bobosha, Kidist
author_sort Atnafu, Abay
collection PubMed
description BACKGROUND: Tuberculosis lymphadenitis (TBLN) diagnosis is often challenging in most resource poor settings. Often cytopathologic diagnosis of TBLN suspected patients is inconclusive impeding timely clinical management of TBLN suspected patients, further exposing suspected patients either for unnecessary use of antibiotics or empirical treatment. This may lead to inappropriate treatment outcome or more suffering of suspected patients from the disease. In this study, an integrated diagnostic approach has been evaluated to elucidate its utility in the identification of TBLN suspected patients. METHODS: A cross-sectional study was conducted on 96 clinically diagnosed TBLN suspected patients, where fine needle aspirate (FNA) samples were collected at the time of diagnosis. FNA cytology, Ziehl-Neelsen (ZN), Auramine O (AO) staining, GeneXpert MTB/RIF and Real time PCR (RT-PCR) were performed on concentrated FNA samples. Considering culture as a gold standard, the sensitivity, specificity, positive and negative predictive values were calculated. Cohen’s Kappa value was used to measure interrater variability and level of agreement and a P-value of <0.05 was considered as statistically significant. RESULT: Out of the 96 FNA sample, 12 (12.5%) were identified to have Mycobacterium tuberculosis (Mtb) using ZN staining, 27 (28.1%) using AO staining, 51 (53.2%) using FNAC, 43 (44.7%) using GeneXpert MTB/RIF, 51 (53.1%) using Real time PCR (RT-PCR) and 36 (37.5%) using Lowenstein-Jensen (LJ) culture. Compared to LJ culture, the sensitivities of GeneXpert MTB/RIF, RT-PCR, and FNAC were 91.7%, 97.2%, and 97.2%, respectively and the specificities were 83.3%, 73.3%, and 68.3%, respectively. GeneXpert MTB/RIF and RT-PCR when combined with FNAC detected 61 (63.5%) cases as having Mtb, and the sensitivity and specificity was 100% and 58.3%, respectively. CONCLUSION: FNA cytology and RT-PCR detected more TBLN cases compared to other Mtb detection tools and the detection sensitivity even improved when FNA cytology was combined with GeneXpert MTB/RIF, performed on concentrated FNA sample, suggesting the combined tests as an alternative approach for improved diagnosis of TBLN.
format Online
Article
Text
id pubmed-8970391
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-89703912022-04-01 Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients Atnafu, Abay Desta, Kassu Girma, Selfu Hailu, Dawit Assefa, Gebeyehu Araya, Shambel Bekele, Dinksira Wassie, Liya Bobosha, Kidist PLoS One Research Article BACKGROUND: Tuberculosis lymphadenitis (TBLN) diagnosis is often challenging in most resource poor settings. Often cytopathologic diagnosis of TBLN suspected patients is inconclusive impeding timely clinical management of TBLN suspected patients, further exposing suspected patients either for unnecessary use of antibiotics or empirical treatment. This may lead to inappropriate treatment outcome or more suffering of suspected patients from the disease. In this study, an integrated diagnostic approach has been evaluated to elucidate its utility in the identification of TBLN suspected patients. METHODS: A cross-sectional study was conducted on 96 clinically diagnosed TBLN suspected patients, where fine needle aspirate (FNA) samples were collected at the time of diagnosis. FNA cytology, Ziehl-Neelsen (ZN), Auramine O (AO) staining, GeneXpert MTB/RIF and Real time PCR (RT-PCR) were performed on concentrated FNA samples. Considering culture as a gold standard, the sensitivity, specificity, positive and negative predictive values were calculated. Cohen’s Kappa value was used to measure interrater variability and level of agreement and a P-value of <0.05 was considered as statistically significant. RESULT: Out of the 96 FNA sample, 12 (12.5%) were identified to have Mycobacterium tuberculosis (Mtb) using ZN staining, 27 (28.1%) using AO staining, 51 (53.2%) using FNAC, 43 (44.7%) using GeneXpert MTB/RIF, 51 (53.1%) using Real time PCR (RT-PCR) and 36 (37.5%) using Lowenstein-Jensen (LJ) culture. Compared to LJ culture, the sensitivities of GeneXpert MTB/RIF, RT-PCR, and FNAC were 91.7%, 97.2%, and 97.2%, respectively and the specificities were 83.3%, 73.3%, and 68.3%, respectively. GeneXpert MTB/RIF and RT-PCR when combined with FNAC detected 61 (63.5%) cases as having Mtb, and the sensitivity and specificity was 100% and 58.3%, respectively. CONCLUSION: FNA cytology and RT-PCR detected more TBLN cases compared to other Mtb detection tools and the detection sensitivity even improved when FNA cytology was combined with GeneXpert MTB/RIF, performed on concentrated FNA sample, suggesting the combined tests as an alternative approach for improved diagnosis of TBLN. Public Library of Science 2022-03-31 /pmc/articles/PMC8970391/ /pubmed/35358212 http://dx.doi.org/10.1371/journal.pone.0265499 Text en © 2022 Atnafu et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Atnafu, Abay
Desta, Kassu
Girma, Selfu
Hailu, Dawit
Assefa, Gebeyehu
Araya, Shambel
Bekele, Dinksira
Wassie, Liya
Bobosha, Kidist
Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients
title Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients
title_full Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients
title_fullStr Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients
title_full_unstemmed Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients
title_short Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients
title_sort integration of cytopathology with molecular tests to improve the lab diagnosis for tbln suspected patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970391/
https://www.ncbi.nlm.nih.gov/pubmed/35358212
http://dx.doi.org/10.1371/journal.pone.0265499
work_keys_str_mv AT atnafuabay integrationofcytopathologywithmolecularteststoimprovethelabdiagnosisfortblnsuspectedpatients
AT destakassu integrationofcytopathologywithmolecularteststoimprovethelabdiagnosisfortblnsuspectedpatients
AT girmaselfu integrationofcytopathologywithmolecularteststoimprovethelabdiagnosisfortblnsuspectedpatients
AT hailudawit integrationofcytopathologywithmolecularteststoimprovethelabdiagnosisfortblnsuspectedpatients
AT assefagebeyehu integrationofcytopathologywithmolecularteststoimprovethelabdiagnosisfortblnsuspectedpatients
AT arayashambel integrationofcytopathologywithmolecularteststoimprovethelabdiagnosisfortblnsuspectedpatients
AT bekeledinksira integrationofcytopathologywithmolecularteststoimprovethelabdiagnosisfortblnsuspectedpatients
AT wassieliya integrationofcytopathologywithmolecularteststoimprovethelabdiagnosisfortblnsuspectedpatients
AT boboshakidist integrationofcytopathologywithmolecularteststoimprovethelabdiagnosisfortblnsuspectedpatients